Documents
Resources
Learning Center
Upload
Plans & pricing Sign in
Sign Out

Curriculum Vitae

VIEWS: 19 PAGES: 38

									                                  Curriculum Vitae

                      Quyen D. Chu, M.D., F.A.C.S.
                                Chief, Surgical Oncology
                      Albert Sklar Endowed Professor of Surgery
                             Associate Professor of Surgery
                  Director, Peritoneal Surface Malignancies Program
                  Louisiana State University Health Sciences Center
                              Feist-Weiller Cancer Center


PERSONAL:

Office Address:            Department of Surgery
                           LSU Health Sciences Center-Shreveport
                           1501 Kings Highway
                           Shreveport, LA 71130

E-mail Address:            qchu@lsuhsc.edu

Telephone:                 (318) 675-6123
FAX:                       (318) 675-6171




Birth Date:                May 11, 1968



Citizenship:               United States




EDUCATION:


                                             1
1990   B.A.                 Dartmouth College
                            Biochemistry, Hanover, NH

1994   M.D.                 Brown Medical School
                            Providence, RI


POSTGRADUATE TRAINING:

Internship and Residency:

1995 - 1997                 Internship in General Surgery,
                            Baystate Medical Center, Springfield, MA

1997 - 1999                 Residency in General Surgery,
                            St. Elizabeth’s Medical Center, Boston, MA

1999 - 2000                 Chief Resident, General Surgery,
                            St. Elizabeth’s Medical Center, Boston, MA


Research Fellowships:

1994 - 1995                 Research Fellow
                            Department of Surgery
                            Brown University School of Medicine, Providence, RI
                            Mentor: Harold J. Wanebo, M.D.


Clinical Fellowship:

2000 - 2002                 Surgical Oncology,
                            Roswell Park Cancer Institute, Buffalo, NY

Postgraduate Courses:

   2003                     Clinical Trials Methods: American College of Surgeons

   2004                     Young Surgical Investigators Conference:
                            Leesburg, VA

   2008                     Mammosite course
                            San Antonio, TX


                                             2
   2008         Disparities in Surgical Care: Research to Practice
                Boston, MA

   2009         2nd Annual Meeting of the Global Burden of Surgical
                Disease Working Group
                Chicago, IL

   2009         ASCO 2009-2010 Leadership Development Program
                Virginia, WA

   2010         Laparoscopic Esophagectomy
                Gainesville, FL

   2011-2013    Executive MBA Program
                Centenary College: Degree Pending


LICENSURE:

1995            State of Massachusetts (Inactive) No. 158025
2000            State of New York (Inactive) No. 216929-1
2002            State of Louisiana No. 14685R

BOARD CERTIFICATION:

2001            American Board of Surgery No. 46594
                Recertification 2010

2002            Surgical Oncology and Endoscopy Certificate: Society of
                Surgical Oncology


SPECIAL CERTIFICATION

1995            Surgical Oncology Basic Science Certification:
                Brown University School of Medicine

1998            Advanced Laparoscopic Solid Organ Surgery:
                Splenectomy and Adrenalectomy: Providence, RI

1998            Trauma Abdominal Ultrasound: Bridgeport Hospital
                Section of Trauma and Surgical Critical Care at USSC,


                                  3
                 Norwalk, Conn

2003             Endorectal Ultrasound. The American Society of Colon
                 and Rectal Surgeons, New Orleans, LA

2003             ATLS re-certification

ACADEMIC APPOINTMENTS:

2002 - 2007      Assistant Professor of Surgery,
                 Louisiana State University,
                 Shreveport, LA

2007 – present   Associate Professor of Surgery, tenured
                 Louisiana State University,
                 Shreveport, LA


HOSPITAL APPOINTMENTS:

2002 - present   Surgical Oncologist, Division of Surgical Oncology,
                 Louisiana State Univ. Health Sciences Center,
                 Shreveport, LA

2003 - 2004      Consultant Surgeon,
                 Overton-Brooks V.A. Medical Center,
                 Shreveport, LA

2003 - present   Consultant Surgeon,
                 Willis-Knighton Medical Center,
                 Shreveport, LA

2004 - present   Consultant Surgeon,
                 Doctor’s Hospital
                 Shreveport, LA

2005-present     Director, Peritoneal Surface Malignancies Program
                 Louisiana State Univ. Health Sciences Center,
                 Shreveport, LA

2008-present     Chief of Surgical Oncology
                 Louisiana State Univ. Health Sciences Center,
                 Shreveport, LA



                                   4
2009-present                  American College of Surgeons Commission on Cancer
                              (CoC) Cancer Liason

MAJOR COMMITTEE ASSIGNMENTS:
International Organization:

2010 – current                National Foundation for Science and Technology
                              Development (NAFOSTED) (Vietnam’s NSF)
                              Biology Leader for Reviewers

National Organizations:


2003 - present                Principal Investigator and Group Leader
                              American College of Surgeon Oncology Group

2004 - present                Southwest Oncology Group (S.W.O.G.)

2005- present                 Association of Academic Surgery Institutional Representative

2008-current                  SWOG Breast Cancer Committee

                              SWOG Gastrointestinal Cancer Committee

                              SWOG Surgery Committee

2009-current                  American College of Surgeons Young Fellows Association
                              Governing Councilor

2010-current                  2010 Nominating Committee
                              Young Fellows Association

2010-current                  2010 International Relations Committee
                              Young Fellows Association

2010-current                  American College of Surgeons Board of Governors:
                              Liaison for International Relations Committee

2010-current                  American Society of Clinical Oncology (ASCO)
                              Program Director: Oncology Training Program in Vietnam

2010-current                  American Society of Clinical Oncology (ASCO)
                              Cancer Education Committee-Member

2010-current                  American Society of Clinical Oncology (ASCO)


                                               5
                           International Cancer Corps (ICC) Member

2010-current               Health Volunteers Overseas (HVO) Oncology
                           Steering Committee

2011 – current             AAS: Publication Committee

2011-current               SUS: Publication Committee


State/Regional Organizations:


2004-2005                  Delegate for 2004 House of Delegates of the
                           Louisiana State Medical Society

2003-2004                  Young Surgeon Representative,
                           LA Chapter, American College of Surgeons

2002 - present             Committee member,
                           Cancer Early Detection and Prevention Group
                           Louisiana Cancer Control Partnership

2008- present              Committee member,
                           Louisiana HealthCare Quality Forum-
                           Quality Measurement Committee

2009-                      Executive Councilor
                           Surgical Association of Louisiana

2010- present              Chair, Resident Surgical Jeopardy
                           Joint Annual Meeting Louisiana Chapter, American
                           College of Surgeons and Surgical Association of Louisiana

2009-                      State Advocacy Representative


Hospital Committees:

2003 - present             Trauma Performance Improvement Committee

2003- present              Resident Promotion Committee

2004 – 2005                Clinical Research Committee

2004 – 2005                Surgery Quality Council Committee



                                            6
2007-present              Infection Control Committee

2007- present             Medical Student Research Committee

2007- present             Medical Student Promotion Committee

2007- present             Breast Cancer Focus Group

2009-present              Surgical Care Improvement Project (SCIP)
                          Chairperson

2009- present             Continuing Medical Education Committee
                          Faculty Advisory Committee

2009-present              Hepatopancreatico-Biliary Multidisciplinary Team
                          Core Member

2010- present             Residency Service Committee: Ad-Hoc
                          Chairperson

2010- present             2010 Joint Commission Process Review Committee

2011- present             Institutional Review Board Member

2011- present             Search Committee for Department of Otolaryngology
                          Committee Member


NON-ACADEMIC ACTIVITIES

2004 – present            Dartmouth College District Enrollment Director
                          for North Louisiana

2004 – present            Brown University interviewer for North Louisiana


PROFESSIONAL SOCIETIES:
National Organizations:

2002                      American Association for Cancer Research*
2002                      Association for Academic Surgery*
2003                      Southwest Oncology Group*


                                           7
2002                    Roswell Park Surgical Society
2002                    American Society for Gastrointestinal Endoscopy*
2002                    American Society of Clinical Oncology*
2000                    Society of Surgical Oncology *
1999                    American College of Surgeons*
2003                    American Society of Breast Surgeons *
2003                    American College of Surgeons Oncology Group *
2005                    American Hepato-Pancreto-Biliary Association *
                        American Society of Gene Therapy*
2009                    American Society of Peritoneal Surface Malignancies

2010                    Society of University Surgeons*

2010                    Surgical Political Advocacy Committee (SPAC)

(*elected membership)


State Organizations:

2003                    Louisiana Chapter, American College of Surgeons
2003                    Louisiana State Medical Society
2003                    Shreveport Medical Society*
2003                    Shreveport Surgical Society*
2003                    Surgical Association of Louisiana*
                        (*elected membership)


HONOR SOCIETIES:
1993                    Sigma Xi Honor Society


AWARDS/HONORS:
1990                    Dartmouth Scholars Award

1990 - 1994             Brown Faculty Scholars Award

                        American Federation of Clinical Research (AFCR) Award


                                         8
              Norton Cancer Institute Research Fellowship Award

              Mt. Sinai Medical Student CPC Competition Award

2000 – 2002   Research Grant Award, Division of Head and Neck
              Surgery

              Roswell Park Cancer Institute, Buffalo, NY

              Travel Grant to CALG-B meeting, Ottawa, ON

              Travel Grant to CALG-B meeting, Amelia Island, FL
2004          Young Surgeon Representative,
              Louisiana Chapter, American College of Surgeons

              Delegate to the Louisiana State Medical Society

2005          Brown University / Bank of America Community Fellows
              Awards

              Health Resources and Services Administration (HRSA) Faculty
              Loan Repayment Program Award

              Team Recognition Award
              Louisiana State Univ. Health Sciences Center,
              Shreveport, LA

2007          2007 ASCO Foundation Merit Award

2008          Shreveport-Bossier Best Doctor

2009          1. Albert Sklar Endowed Professorship
              2. ASCO 2009-2010 Leadership Development Program
              3. U.S. Faculty Scholar Award from Vietnam Education
                 Foundation
              4. Shreveport-Bossier Best Doctor
              5. USA Today “Most Influential Doctors”

2010          1. VFW Ladies Auxillary Cancer Award
              2. U.S. Faculty Scholar Award from Vietnam Education
                 Foundation
              3. International Teaching Award from Thai-Binh Medical
                 University, Vietnam
              4. Shreveport-Bossier Best Doctor
              5. USA Today “Most Influential Doctors”



                               9
INITIATED PROJECTS
2009                      Program Director
                          16th Annual Carroll W. Feist Scientific Symposium on
                          Hepatocellular Carcinoma

2009                      July 17, 2009
                          Program Director
                          1st Annual Hepatopacreatobiliary Conference
                          November 20, 2009

2010                      July 23, 2010
                          Program Director
                          17th Annual Carroll W. Feist Scientific Symposium on
                          Esophageal Carcinoma

2010                      October 3-13, 2010
                          First International Vietnam-American Surgical Symposium
                          Hanoi, Vietnam
                          Program Director

2010                      Coordinator of Surgical Grand Rounds
                          Biology of Colorectal Neoplasia
                          Thomas J. McGarrity, M.D.
                          April 6, 2010

2011                      Coordinator for 97th Annual Clinical Congress of American
                          College of Surgeons, “Volunteering: Making Service Happen”.
                          San Francisco, CA , October 23-27, 2011.

2011                      April 15-25
                          First Annual Joint ICS/Operation Hope and AHPBA Medical
                          Symposium, Kurdistan, Iraq
                          Program Director

2011                      Host & Coordinator for 2012 Vietnam Education
                          Foundation (VEF) Annual Conference
                          Shreveport, LA



TEACHING EXPERIENCE:

2000-2002   Lecturer, Roswell Park Cancer Institute Fellow’s Lecture Series


                                           10
              1 lecture per year

2002 - present Clinical Preceptor, Lecturer and Attending Surgeon,
               Surgical Oncology Service, LSU Health Sciences Center,
               Shreveport, LA


2003 - present Co-Coordinator, Multidisciplinary Tumor Board,
               LSU Health Sciences Center
               Weekly meeting

2003 - present Co- Coordinator, Surgical Oncology Journal Club,
               LSU Health Sciences Center
               Weekly meeting

2003 - present Surgical Oncology Laboratory Meeting,
               LSU Health Sciences Center
               Weekly meeting

2002 - present Faculty, Surgery Grand Rounds,
               LSU Health Sciences Center
               2 lectures per year

2003 - present Faculty, Oral Examinations to Residents
               LSU Medical School – Shreveport
               4 Examinations per year

1996 - 2000   Faculty, 3rd year Medical Students Lecture
              LSU Health Sciences Center
              3 lectures per year

2003          Surgery Grand Rounds
              Pancreatic Cancer

2003          Faculty speaker, 5th Annual Red River Gastrointestinal Conference
              Shreveport, LA

2004          Surgery Grand Rounds
              Gastric Cancer

2004          Surgery Grand Rounds
              Retroperitoneal Sarcoma

2004          Surgery Grand Rounds
              Surgical Oncology Research Program




                                              11
2004   Surgery Grand Rounds
       Hematologic Indications for Splenectomy

2005   Phoenix Multidisciplinary Cancer Symposium
       Gastrointestinal Carcinoid Tumors

2005   Surgery Grand Rounds
       Prophylactic Surgery for Inherited Cancer Syndrome

2006   Surgery Grand Rounds
       Adjuvant Therapy for Node Positive Breast Cancer

2006   Head and Neck Grand Rounds
       Current Management of Esophageal Cancer

2006   Asian/Pacific Islander Diversity Awareness Talk
       National Weather Service

2007   LCPPC: Current Perspectives on Management of Colorectal Cancer

2007   Surgery Grand Rounds
       Translational Breast Cancer Research

2007   How to Perform a Proper Breast Examination
       Lecture to Second Year Medical Student

2007   Surgical Faculty Mentor for 1st year Medical Students

2008   Hepato-Pancreato-Biliary Disorders
       Lecture to Physician Assistant Students

2008   How to Perform a Proper Breast Examination
       Lecture to Second Year Medical Student

2008   Surgical Faculty Mentor for 1st year Medical Students

2009   Hepato-Pancreato-Biliary Disorders
       Lecture to Physician Assistant Students

2009   Melanoma
       Grand Rounds

2009   How to Perform a Proper Breast Examination
       Lecture to Second Year Medical Student

2009   Surgical Faculty Mentor for 1st year Medical Students



                                      12
2010          Hepato-Pancreato-Biliary Disorders
              Lecture to Physician Assistant Students

2010          How to Perform a Proper Breast Examination
              Lecture to Second Year Medical Student

2010          Surgical Faculty Mentor for 1st year Medical Students

2011          Melanoma
              Grand Rounds


2011          Sarcoma
              Grand Rounds

LABORATORY/RESEARCH MENTORSHIPS:

                             Years in Lab         Present Position


Undergraduates/High School:


Melissa Macynski             2003                 Louisiana College
                                                  Pineville, LA

Joshua Lee Jordan            2003                 C. E. Byrd High School
                                                  Shreveport, LA

Marco Reyes                  2004                 Bossier High School
                                                  Bossier City, LA

Chiemeka Izundu              2004                 Woodlawn High School
                                                  Shreveport, LA

Takazvida A. Nyaundi         2004                 Wiley College
                                                  Marshall, TX

Lisa Sun                     2005                 Magnet High
                                                  Shreveport, LA

Rani Veda                    2006                 University of Louisiana, Monroe
                                                  Shreveport, LA




                                             13
Robert Grand              2006-2011             Caddo Magnet High
                                                Shreveport, LA

Matthew Pope              2009-2011             Ouachita Baptist University
                                                Arkadelphia, Arkansas

Medical Students

Julie Guidroz             2005                  LSU-Shreveport
                                                Shreveport, LA

John Navas                2005                  LSU-Shreveport
                                                Shreveport, LA

Taylor Robertson          2007                  LSU-Shreveport
                                                Shreveport, LA

Anthony Flowers           2008                  LSU-Shreveport
                                                Shreveport, LA

David Hiller              2008-10               LSU-Shreveport
                                                Shreveport, LA

Krista Pennington         2008-10               LSU-Shreveport
                                                Shreveport, LA

Hannah Bauer              2010                  LSU-Shreveport
                                                Shreveport, LA

Justin Rudd               2010                  LSU-Shreveport
                                                Shreveport, LA

Ashley Arnold             2010                  LSU-Shreveport
                                                Shreveport, LA


Postgraduate Fellows/Residents:



Stephen White, M.D.       2003 - present        General Surgery Resident,
                                                LSU Health Sciences Center
                                                Shreveport, LA

Derek McClusky, M.D.      2003 - present        General Surgery Resident,
                                                LSU Health Sciences Center



                                           14
                                               Shreveport, LA


Kerry Byrnes, M.D.       2003 - present        General Surgery Resident
                                               LSU Health Sciences Center
                                               Shreveport, LA


Mohamed Alassas, M.D.    2003 - present        General Surgery Resident
                                               LSU Health Sciences Center
                                               Shreveport, LA

Ryan Wolfort, M.D.       2004                  General Surgery Resident
                                               LSU Health Sciences Center
                                               Shreveport, LA

M. Scott Connor, M.D.    2004                  Oral Maxillofacial Surgery Resident
                                               LSU Health Sciences Center
                                               Shreveport, LA

Salvador Vazquez, M.D.   2004                  General Surgery Resident
                                               LSU Health Sciences Center
                                               Shreveport, LA

Eric Amy, M.D.           2004                  General Surgery Resident
                                               LSU Health Sciences Center
                                               Shreveport, LA

Neil Holm, M.D.          2006                  General Surgery Resident
                                               LSU Health Sciences Center
                                               Shreveport, LA

Mark Smith, M.D.         2008-11               General Surgery Resident
                                               LSU Health Sciences Center
                                               Shreveport, LA

Catherine Parker, M.D.   2009-11               General Surgery Resident
                                               LSU Health Sciences Center
                                               Shreveport, LA

Amanda Henderson, M.D.   2009-11               General Surgery Resident
                                               LSU Health Sciences Center
                                               Shreveport, LA

AWARDS AND HONORS WON BY RESIDENTS/STUDENTS:



                                          15
Wolfort, Ryan, M.D.      2005        State Cancer Paper Competition Winner
                                     American College of Surgeons, LA-Chapter

Byrnes, Kerry, M.D.      2005        2nd place State Cancer Poster Competition
                                     American College of Surgeons, LA-Chapter

                                     Winner of the 2005 Jim Cardelli Barlow Symposium
                                     Award

Salvador Vazques, M.D.   2006        State Cancer Paper Competition Winner
                                     American College of Surgeons, LA-Chapter

Lisa Sun, B.A.           2006        First Place Winner of State-Wide Medicine and
                                     Health Research Competition

Neal Holm, M.D.          2007        2007 ASCO Foundation Merit Award

Neal Holm, M.D.          2007        American Cancer Society/ LA. Cancer
                                     Competition Award

Neal Holm, M.D.          2008        American Cancer Society/LA. Cancer
                                     Competition Award

David Hiller             2009        Finalist in the AAS Outstanding Medical Student
                                     Presentation

Neal Holm, M.D.          2010        Best Resident Presentation Award-Department of
                                     Surgery LSUHSC-S

Mark Smith, M.D.         2010        American Cancer Society/LA. Cancer
                                     Competition Award

Mark Smith, M.D.         2010        Best Resident Presentation Award-Department of
                                     Surgery LSUHSC-S

Catherine Parker, M.D.   2010        Best Resident Presentation Award-Department of
                                     Surgery LSUHSC-S

David Hiller             2011        Winner of the Association for Academic
                                     Surgery (AAS) Student Research Award

Ashley Arnold            2011

Catherine Parker, M.D.   2011        Winner of Best Oral Presentation at LA-ACS &
                                     SAL Annual Meeting



                                16
Amanda Henderson           2011                  Winner of Best Poster Presentation at LA-ACS &
                                                 SAL Annual Meeting


RESEARCH FUNDING:

1.    Agency: Feist-Weiller Cancer Grant                         Amount: $20,000
      Title: The Role of Gene Therapy in a Rat Peritoneal
             Carcinomatosis Model
      Role: Principal Investigator                               Effort: 20%
      Period of Grant: 1/06-1/07

2.    Agency: Susan G. Komen Foundation                          Amount: $95,436
      Title: Patient Navigation Program for Breast Cancer
      Role: Principal Investigator                               Effort: 10%
      Period of Grant: 4/09-3/2010

3.    Agency: Vietnam Education Foundation                       Amount: $55,000
      Title: Fundamentals of General Surgery
      Role: Principal Investigator                               Effort: 20%
      Period of Grant: 9/09-6/2010

4.    Agency: LA Gene Therapy Consortium                         Amount: $25,000
      Title: CRAd-CXCR4-UTR-E1a.Fiber5/3s in In Vitro
      and In Vivo Model of Pancreatic Cancer
      Role: Principal Investigator                               Effort: 10%
      Period of Grant: 7/09-6/2010

5.    Agency: Pharmaceutical Companies                           Amount: $13,000
      Title: 16th Annual Carroll W. Feist Scientific Symposium
      on Hepatocellular Carcinoma
      Role: Program Director                                     Effort: 20%
      Period: 7/17/2009

6.    Agency: Pharmaceutical Companies                           Amount: $14,000
      Title: 1St Annual Regional Hepato-Pancreato-Biliary
      Symposium on Pancreatic Carcinoma
      Role: Program Director                                     Effort: 20%
      Period: 11/20/2009

7.    Agency: Pharmaceutical Companies                         Amount: $14,000
      Title: 17th Annual Carroll W. Feist Scientific Symposium
      on Esophageal Carcinoma
      Role: Program Director                                   Effort: 20%
      Period: 7/23/2010


                                            17
8.       Agency: Department of Defense                              Amount: $75,000
         Title: Integrin (α6β4) Regulation of Lipid Rafts Signaling
         Role: Co-Investigator                                      Effort: 20%
         Period: 5/2010 through 5/2011

9.       Agency: Vietnam Education Foundation                        Amount: $55,000
         Title: Multidisciplinary Approach in Managing
         Breast Cancer
         Role: Principal Investigator                                Effort: 20%
         Period: 10/25/2010-3/31/2011

10.      Agency: R01 CA 112282-06A1
         Title: The Role of CDC25A in Breast Cancer
         Role: Co-Investigator                                       Effort: 5%
         PI: Hiroaki Kiyokawa, Ph.D.
         Period: 7/1/11-6/30/13


EDITORIAL DUTIES:
      1. NIH Challenge Grant Reviewer 2009

      2. Editorial Board:

         a. Virus, Adaptation and Treatment

         b. Global Journal of Surgery

         c. Louisiana State Medical Society

      3. Invited Editor

         a.   Lead Guest Editor for International Journal of Breast Cancer

      4. Guest Reviewer

         a. Breast Cancer Research and Treatment

         b. Annals of Surgical Oncology

         c. AAMC MedEdPORTAL Reviewer

         d. BioMED Central

         e. European Journal of Obstetrics and Gynecology and Reproductive Biology


                                                 18
            f. The Breast

            g. Canadian Journal of Surgery

            h. Journal of the Pancreas

            i. Community Oncology

            j. Advanced Drug Delivery Reviews



      REFEREED PUBLICATIONS (Articles, Abstracts, and Proceedings):
1.    Chu Q.D. The Jigsaw Puzzle. The Rhode Island Medicine 1994;77:68-9.
2.    Chougule PB, Suk S, Chu Q.D., Leone L, et al. The Role of Cis-Platinum as a Potent Radiation
      Sensitizer in the Treatment of Advanced Head and Neck Cancers: Result of a Phase II Study.
      Cancer 1994;74:1927-32.
3.    Chu Q.D., Vezeridis M, Libbey N, Harold J. Wanebo. Giant Condyloma Acuminatum
      (Buschke-Loewenstein Tumor) of the Anorectal and Perianal Regions: Analysis of 42 Cases.
      Diseases of the Colon and Rectum 1994;37:950-7.
4.    Chu Q.D., Medeiros LJ, Fisher A, Crowley J. Thrombotic Thrombocytopenic Purpura (TTP)
      and HIV Infection. Southern Medical Journal 1995;88:82-6.
5.    Chu Q.D., Shrayer DP, Wanebo HJ. Biphasic effect of cisplatin and taxol on B16 F10 melanoma
      cells. Proceedings of the 86th Annual Meeting of the American Association for Cancer Research
      1995;36:2218.
6.    Wanebo HJ, Chu Q.D., Avradopoulos KA, Vezeridis MP. Current Perspectives on Repeat
      Hepatic Resection for Colorectal Carcinoma: A review: Surgery 1996; 119:361-71.
7.    Wanebo HJ, Chu Q.D., Vezeridis MP, Soderberg C. Patient Selection for Hepatic Resection for
      Colorectal Metastases. Archives of Surgery 1996: 131;322-9.
8.    Chu Q.D., Simon B, Emhoff T, Fiallo V, Lee KF. Age, Mechanism of Injury, and Injury Severit
      Score as Predictors of Financial Outcome in Regional Pediatric Trauma Care: A New Outcome-
      Based Injury-Prevention Strategy. Surgical Forum Vol 47: 1997;643-6.
9.    Chu Q.D., Vezeridis M, Avradopoulos KA, Wanebo HJ. Repeat Hepatic Resection for
      Recurrent Colorectal Cancer. World J Surg 1997;21:292-6.
10.   Simon B, Chu Q.D., Emhoff T, Fiallo V, Lee KF. Delayed hemothorax following blunt
      thoracic trauma. An uncommon entity with significant morbidity: J Trauma 1998; 45:673-6.
11.   Chu Q.D., James Petros. Extraperitoneal rectal perforation due to retroflexion
      fiberoptic proctoscopy. American Surgeon 1998;65:81-5.
12.   Tehrani HY, Petros JG, Kumar RR, Chu Q.D. Markers of severe appendicitis.
      American Surgeon 1999; 65:453-5.
13.   Chu Q.D., Hill H, Wiseman S, Loree T, Rigual N, Hicks W. Squamous cell carcinoma of the lip
      Nodal stage remains the most accurate predictor of outcome for stage III/IV disease. American
      Head and Neck Society 2001
14.   Chu Q.D., Smith J, Nava H, Douglass H, Driscoll D, Gibbs JF. Neuroendocrine tumor of the


                                                 19
      pancreas. The Roswell Park Experience. Ann Surg Oncol 2002; 9: 101.
15.   Chu Q.D., Smith J, Nava H, Douglass H, Gibbs J. Phase II trial of infusional 5-fluorouracil,
      mitomycin C, and external beam radiation followed by pancreatectomy for patients with locally
      advanced adenocarcinoma of the pancreas. A long-term follow-up.
      Proceedings of American Society of Clinical Oncology 2002; 21: A2304.
16.   Gibbs J, Penetante R, Martinick M, Chu Q.D., Driscoll D, Hurd T, Markus G, Harvey S.
      Immunohistochemical evaluation of urinary plasminogen activator (uPA), its receptor (uPAR),
      matrixmetalloproteinases-9 (MMP-9) and von Willebrand factor (vWF) in pancreatic cancer.
      Proceedings of the American Association Cancer Research 2002; 43: A1974.
17.   Wiseman S, Hicks W, Chu Q.D., Rigual NR. Sentinel lymph node biopsy in staging of
      differentiated thyroid cancer: A critical review: Surg Onc 2002;11:1-8.
18.   Donias HW, Chu Q.D., Anderson TM, Karamanoukian RL, Gibbons WJ, Karamanoukian HL.
      Bronchogenic cysts presenting as thymic cysts. Contemporary Surg 2002;58:562-5.
19.   Wiseman S, Chu Q.D., Hicks W, Rigual NR, Popat S, et al. Patient characteristics and treatment
      outcome of parathyroid carcinoma. Otolaryngology-Head and Neck Surgery 2002;127:115.
20.   Chu Q.D., Davidson R, Rodriguez-Bigas M, Wirtzfeld D, Petrelli N. Is abdominoperineal
      resection a good option for stage IV adenocarcinoma of the distal rectum?
      J Surg Onc 2002;81:3-7.
21.   Chu Q.D., Hill H, Smith J, Nava H, Douglass H, Driscoll D, Gibbs. Predictive factors associated
      with long term survival in patients with neuroendocrine tumor of the pancreas. Ann Surg Onc
      2002;9:855-62.
22.   Chu Q.D., Al-kasspooles M, Smith J, Nava H, Douglass H, Driscoll D, Gibbs J. Is glucagonoma
      of the pancreas a curable disease? International Journal of Pancreatology 2002: 29:155-62.
23.   Chu Q.D., Hurd T, Harvey S, Martinick M, Penetrante R, Hicks W, Rigual N, Loree T. Urinary
      plasminogen activator (uPA) is expressed in papillary thyroid carcinoma but not in benign thyroid
      tumor. Annual Meeting of American Head and Neck Society 2002, pg. 34.
24.   Chu Q.D., Smith J, Nava H, Douglass H, Driscoll D, Gibbs JF. Neoadjuvant treatment followed
      by pancreatectomy for patients with locally advanced adenocarcinoma of the pancreas. A long
      term follow-up. Current Surgery 2002;59:577.
25.   Chu Q.D., Smith J, Nava H, Douglass H, Driscoll D, Gibbs JF. Aggressive treatment associated
      with long-term survival in patients with neuroendocrine tumor of the pancreas. Current Surgery
      2002;59:578.
26.   Chu Q.D., Khushalani N, Javle M, Douglass H, Gibbs J. Should adjuvant therapy remain
      standard of care for patients with resected adenocarcinoma of the pancreas?
      Ann Surg Onc 2003;10:539-45.
27.   McClusky, D., Gauthier, M., Meschonat, C., Chu, Q., Li, B.D.L. High eIF4E Predicts Cancer
      Recurrence in Node-positive Breast Carcinoma. Proceedings of the American Association for
      Cancer Research, 44:297, 2003.
28.   McClusky, D., Gauthier, M., Meschonat, C., Chu, Q., Alley, J.A., Sehon, K., Johnson, L.W.,
      Li, B.D.L. High eIF4E Predicts Recurrence in Node-negative Breast Cancer Patients.
      Proceedings of the American Society for Clinical Oncology, 22:851, 2003.
29.   Ethridge, L., Macynski, M., Chu, Q., McClusky, Turnage, R., Li, B.D.L. Referral to American
      Cancer Society May Not Improve the Quality of Life for Patients with Breast Cancers.
      Proceedings of the Lynn Sage Breast Cancer Symposium 5:B7, 2003.
30.   Chu, Q.D., Turnage, R.H., Burton, G., Ampil, F., McDonald, J.C., Li, B.D.L. Neoadjuvant
      Chemotherapy Attenuates the Overexpression of eIF4E in Patients with Breast Carcinomas.



                                                   20
      Proceedings of the 2nd Annual AACR Frontiers in Cancer Prevention Research 2:86-87, 2003.
31.   Hoshi H, Foster J, Chu Q.D., Kuvshinoff B, Rajput A, Nava H, Gibbs J. Radical resection is
      indicated for all T2 and T3 gallbladder cancers and results in the same survival as primarily
       resected gallbladder cancers. Annals of Surg Onc 11 (2): 98, 2004
32.   Chu, Q.D., D. McClusky, Turnage, R.H., Johnson, L.W., McDonald, J.C., Li, B.D.L. Impact
      Of eIF4E Overexpression On Survival In Advanced Breast Cancer. Annals of Surg Oncol
      11(2): 42, 2004.
33.   Chu, Q.D., Turnage, R., McClusky, D., Meschonat, C., Li, B.D.L. Overexpression of
      Eukaryotic Initiation Factor 4E (eIF4E) in Soft Tissue Neoplasms. Proceedings of the AACR
      45:4285, 2004.
34.   Chu, Q.D., Johnson, L.W., Li, B.D.L. Management of Retroperitoneal Sarcoma. Journal of
      the LA State Medical Society 156(2):95-98, 2004.
35.   White, S., Ampil F., Burton G., Li B.D.L., Chu Q.D. Is Breast Conservation an Acceptable
      Alternative for Breast Cancer Patients with Collagen Vascular Diseases? Annals of Surg Oncol
      11(2): 43, 2004.
36.   Wolfort, R.M., Li, B.D.L., Ramaswamy, M., Turnage, R.T., Ampil, F., Burton, G., Chu, Q.D.
      The Role of Positron Emission Tomography in the Detection of Metastasis in Symptomatic
      Patients with Stage II and III Breast Cancer. Proceedings of the ASCO 23:56, 2004.
37.   Connor, M.S., Li, B.D.L., Ramaswamy, M., Turnage, R.T., Chu, Q.D. PET-Positive Thyroid
      Incidentalomas: Characteristics and Risks of Malignancy Observed in a Tertiary Referral
      Center. Proceedings of the ASCO 23:495, 2004.
38.   Alassas M, Chu QD, Burton GV, Ampil F, Li BDL. Impact of Neoadjuvant Therapy on Stage
      III Breast Cancer Outcome. Southeastern Surgical Association 2004
39.   Chu QD, Li J, Byrnes K, McClusky D, Okadata Y, De Benedetti A, Mathis M, Turnage R, Li
      BDL. A Translational Restricted HSV-TK/GCV Gene Increases Disease-Free and Overall
      Survival in a Minimal Residual Rat Breast Cancer Model. J Surg Research 2004;121:280.
40.   Byrnes K, Li J, Chu QD, Mathis M, Sibley D, Odaka Y, De Benedetti A, Turnage R, Li BDL.
      Using an Ad-HSV-UTK Gene Construct to Exploit eIF4E Overexpression in Tumor Cells to
      Improve Outcome. Society of University Surgeons 2005; 110:A66
41.   Vazquez, S, Byrnes, K, Chu, Q.D., Cole, P, Li, B.D.L, Stratton, M. Eukaryotic Initiation
      Factor 4E (eIF4E) Expression in Malignant Versus Inflammatory Colon Tissue. Ann Surg Onc
      2005;S12:A167
42.   Byrnes KW, Li B, Ampil F, Burton G, Abbas M, Johnson L, Chu QD. Effect of neoadjuvant
      chemotherapy on eIF4E expression in breast carcinoma. Ann Surg Onc 2005;S12;A101.
43.   Chu QD, Hurd TC, Harvey S, Martinick M, Markus G, Tan DF, Gibbs JF, Loree T.
      Overexpression of Urinary Plasminogen Activator (uPA) Protein and mRNA in Thyroid
      Malignancies. Diagnostic Molecular Pathology 2004;13:241-246.
44.   Byrnes K, Norton K, Chu QD, Yu H, Johnson L, Sehon K, Alley J, Meschonet C, Abbas M, Li
      B. Eukaryotic initiation factor 4E elevation increases risk for cancer recurrence and death in
      node-negative breast cancer patients. DoD 2005
45.   Ampil F, Burton G, Li BDL, Chu Q, Krishnamsetty RM, Caldito G. Thoracic metastases from
      breast cancer: A single-institution’s experience. Eur J Gynaec Onc 2005;26:155-7.
46.   Alassas M, Chu Q, Burton G, Ampil F, Mizell J, Li BDL. Neoadjuvant chemotherapy in stage
      III breast cancer. American Surgeon 2005;71:487-92.
47.   Zibari G, Byrnes K, Whitlock M, Chu QD, Maley W, Lilian D, Johnson L, McDonald JC,
      Turnage R. FDG-PET is Superior to CT Scanning for Detecting Hepatic Recurrence in Liver



                                                   21
      Resection Patients. Southern Surgical Assocation 2005.
48.   Byrnes K, White SC, Abreo F, Yu H, Meschonat C, Johnson L, Chu Q, Turnage R, Li B.
      eIF4E overexpression, angiogenesis, and breast cancer outcome. Southern Surgical Association
      2005.
49.   Hoshi H, Foster J, Chu Q.D., Smith JL, Driscoll D, Nava HR, Gibbs JF. Results of Radical
      resection for T2 and T3 gallbladder cancers. Ann Surg Onc 2004
50.   Wolfort RM, Byrnes KW, Li DLB, Turnage RH, Lilien D, Chu QD. The Role of Positron
      Emission Tomography in the Evaluation of Local Recurrence and Distant Metastasis in Stage
      III Breast Cancer Patients. ASCO 2005.
51.   Kleiner HE, Campbell CTD, Prince M, Robertson TA, Krishman P, Li DL B, Chu QD.
      Anticarcinogenic effects of citrus Auraptene on rat breast cancer. 28th Annual San Antonio
      Breast Cancer Symposium 2005.
52.   Wolfort RM, Chu QD, Turnage RH, Yu H, Nuthalapaty S, DeBenedetti A, Li DL B.
      Upregulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated breast
      cancer patients. JSR 2006;130:218.
53.   Byrnes, K.W., Li, B.D.L., Li, J., Turnage, R., Chu, Q. Apoptosis in a Malignant Cell Line
      Induced by a Novel Suicide Gene Therapy Exploiting Elevated Levels of Eukaryotic Initiation
      Factor 4E. JSR 2006;130: 256
54.   Byrnes KW, DeBenedetti A, Holm N, Luke J, Nunez J, Chu Q, Meschonat C, Abreo F,
      Johnson LW, Li BDL. Correlation of TLK1B Elevation and Recurrence in doxorubicin-treated
      breast cancer patients with high eIF4E overexpression. Transactions of the Southern Surgical
      Association 2006;118:173-82.
55.   Byrnes K, White S, Chu Q, Meschonat C, Yu H, Johnson LW, DeBenedetti A, Abreo F,
      Turnage R, McDonald JC, Li BDL. High eIF4E, VEGF, and Microvessel density in stage I to
      III breast cancer. Transactions of the Southern Surgical Association 2005;117:129-137
56.   White, S.C., Chu Q., Gruner J.S., Abreo, F.W., Yu,H., Johnson, L.W., Li, B.D.L. eIF4E
      Overexpression, Angiogenesis, and Breast Cancer Outcome. Southern Surgical Association
      2006
57.   Byrnes K, Hussain U, Li B, Ampil F, Burton G, Turnage R, Chu QD. Cost Analysis of Breast
      Conservation Therapy versus Simple Mastectomy with or without Reconstruction for Patients
      with Ductal Carcinoma In-Situ (DCIS). Ann Surg Onc 2006;13:91.
58.   Chu QD, Connor MS, Lilien D, et al. Positron Emission Tomography (PET) Positive Thyroid
      Incidentaloma: The Risk of Malignancy Observed in a Tertiary Referral Center. American
      Surgeon 2006;72:272-5.
59.   McClusky D, Chu QD, Yu H, DeBenedetti A, Johnson LW, Meschonat C, Turnage R,
      McDonald J, Abreo F, Li BDL. A prospective trial on initiation factor 4E (eIF4E)
      overexpression and cancer recurrence in node-positive breast cancer. Ann Surg 2006;242:584-
      92.
60.   Wolfort R, Li BDL, Johnson LW, Turnage RH, Lilien D, Ampil F, Burton G, Chu QD. The
      role of whole-body fluorine-18-FDG Positron Emision Tomograph (FDG-PET) in the detection
      of recurrence in symptomatic patients with stage II and III breast cancer. World J Surgery
      2006;30:1-6
61.   Byrnes K, White S, Chu QD, Meschonat C, Yu H, Johnson L.W., DeBenedetti A., Abreo F.,
      Turnage R, McDonald J. C., Li B.D.L. High eIF4E, VEGF, and Microvessel Density in Stage
      I to III Breast Cancer. Annals of Surgery 243(5):684-692, 2006.
62.   Wolfort, R., Chu, Q.D., Turnage, R.H., Yu, H., Nuthalapaty, S., DeBenedetti, A., Li, B.D.L.



                                                  22
      Upregulation of TLK1B by eIF4E Overexpression Predicts Cancer Recurrence in Irradiated
      Patients With Breast Cancer. Surgery 2006;140:161-9.
63.   Esquivel J, Sticca R, Sugarbaker P, Levine E, Yan TD, Alexander R, Baratti D, Bartlett D,
      Barone R, Barrios P, Bieligk S, Bretcha-Boix P, Chang CK, Chu F, Chu Q, et al.
      Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy in the management of
      peritoneal surface malignancies of colonic origin: A consensus statement. Ann Surg Onc
      2007;14:128-33.
64.   Byrnes K, Li B, Li J, Mathis M, DeBenedetti A, Odaka Y, Nedeljkovic-Kurepa A, Chu QD. A
      novel suicide gene therapy targeting the overexpression of eukaryotic initiation factor 4E
      improves survival in a rat model of peritoneal carcinomatosis. JSR 2007;137:228.
65.   Holm N, Byrnes K, Li B, Turnage R, Mathis J, Chu QD. High chemokine receptor CXCR4 in
      cancer specimens predicts recurrence in HER-2 negative breast cancer. JSR 2007;137:176.
66.   Holm N, Byrnes K, Luke J, Chu QD, Li BDL. Risk for residual cancer after a margin-positive
      biopsy. Ann Surg Onc 2007;14:82 (P168).
67.   Foster J, Hoshi H, Gibbs J, Iyer R, Javle M, Chu Q, Kusvshinoff B. Gallbladder cancer:
      defining the indications for primary radical resection and radical re-resection. Ann Surg Onc
      2007;14:833-40.
68.   Ampil F, Burton G, Caldito G, Li B, Chu QD. Long Bone Metastases in breast cancer:
      experience of 47 patients. Chin J Clin Oncol 2007;Supple:pg 17.
69.   Holm N, Byrnes K, Siegele B, Li B, Odaka Y, Mathis M, Chu QD. A novel conditionally
      replicative adenovirus gene therapy targeting overexpression of chemokine receptor CXCR4 in
      a pancreatic cancer cell line. HPB 2007;9: Suppl (1): 70
70.   Byrnes K, Holm N, Siegele B, Li B, Mathis M, Odaka Y, Chu QD. A novel suicide gene
      therapy regimen targeting the overexpression of eukaryotic initiation factor 4E in a pancreatic
      cancer cell line. HPB 2007;9: Suppl (1):46
71.   Byrnes K, DeBenedetti A, Holm N, Luke J, Nunez J, Chu QD, Meschonat C, Fleurette A,
      Johnson L, Li BDL. Correlation of TLK1B in elevation and recurrence in doxorubicin-treated
      breast cancer patients with high eIF4E overexpression. J Am College Surg 2007;204:925-34.
72.   Holm N, Byrnes K, Li B, Turnage R, Abreo F, Mathis J, Chu QD. Elevated levels of
      chemokine receptor CXCR4 in HER-2 negative breast cancer specimens predict recurrence.
      JSR 2007;141:53-9.
73.   Holm N, Byrnes K, McDonald M, Abreo F, Ampil F, Sanders M, Burton G, Li B, Chu QD.
      Overexpression of Chemokine Receptor CXCR4 in Cancer specimens following neoadjuvant
      chemotherapy predicts outcome in patients with locally advanced breast cancer (LABC). J Clin
      Oncol 2007;25(18S):584s.
74.   Chu Q.D., Sun L, Byrnes, K.W., Li, J., Turnage, R., Li B.D.L. Apoptosis in a Malignant Cell
      Line Induced by a Novel Suicide Gene Therapy Exploiting Elevated Levels of Eukaryotic
      Initiation Factor 4E. J Surg Research 2007;143: 189-194.
75.   Byrnes K, Li B, Holm N, Li J, Okadata Y, De Benedetti A, Mathis M, Chu Q. A novel suicide
      gene therapy targeting the overexpression of eukaryotic initiation factor 4E improves survival
      in a rat peritoneal carcinomatosis model. Surgery 2007;142:270-5.
76.   Ampil FL, Sanders ME, Caldito G, Chu Q, Burton GV, Li BDL Li. Long bone metastases in
      breast cancer: Experience of 47 patients. Proc 4th Congress of the World Society for Breast
      Health 2007.
77.   Holm N, Li B, Turnage R, Johnson L, Chu Q.D. Chemokine Receptor CXCR4 overexpression
      predicts recurrence for hormone-receptor positive, node-negative breast cancer patients. J Surg



                                                   23
      Res 2008;144(2):319.
78.   Siegele B, Cefalu C, Holm N, Sun G, Chu Q, Tubbs J, Meschonat C, et al. Translation
      initiation factor eIF4E targeted suicide gene therapy following cytoreductive surgery improves
      disease-free survival in a mouse soft tissue metastasis model for head and neck squamous cell
      carcinoma. 3rd Annual Academic Surgical Congress 2008, p. 246 Abstract # 156
79.   Chu QD, Tubbs J, Robertson T, et al. Hypoxia induces CXCR4 overexpression in pancreatic
      cancer cells. AACR 2008; #4472.
80.   Holm N, Abreo F, Johnson L, Li B, Chu QD. Elevated chemokine receptor CXCR4
      expression in primary tumors following neoadjuvant chemotherapy predicts poor outcomes for
      patients with locally advanced breast cancer (LABC). Breast Cancer Research & Treat
      2009;113:293-9.
81.   Ampil FL, Abreo F, Baluna RG, Caldito G, Burton GV, Li BDL, Chu Q. Cancerization of the
      lobules with pre-invasive or early invasive carcinoma of the breast: Management and outcome
      study. Proc of UICC World Cancer Congress 2008.
82.   Holm N, Johnson L, Li B, Chu Q. Overexpression of chemokine receptor CXCR4 in cancer
      specimens predicts outcome in patients with triple-negative breast cancer. Proceedings of the
      Journal of Clinical Oncology 2008;26 (15S):593s #11064.
83.   Holm H, Byrnes K, Sehon K, Johnson LW, Alley J, Meschonat C, Chu Q, Li BDL. eIF4E
      overexpression, cancer recurrence, and death in node-negative breast cancer. Ann Surg Onc
      2008;15(S2):24.
84.   Holm N, Byrnes K, Johnson L, Abreo F, Sehon K, Alley J, Meschonat C, Chu Q, Li BDL. A
      prospective trial on initiation factor 4E (eIF4E) overexpression and cancer recurrence in node-
      negative breast cancer. Ann Surg Onc 2008;15:3207-3215.
85.   Ampil F, Abreo F, Li B, Baluna R, Burton G, Chu Q. Management of cancerisation of the
      lobules with pre-invasive or invasive breast carcinoma: a case series. J Radiotherapy in
      Practice 2008 (7):229-31.
86.   Siegele B, Cefalu C, Holm N, Sun G, Tubbs J, Meschonat C, Odaka Y, DeBenedetti A, Ghali
      G, Chu Q, Mathis J, Li BDL. eIF4E targeted suicide gene therapy in a minimal residual mouse
      model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free
      survival. J Surg Research 2008;148:83-9
87.   Barnidge M, Vea R, Rau B, Chu Q, Behm W, D'Agostino H. Management of postoperative
      chylothorax utilizing percutaneous CT-guided drainage. J Louisiana State Med Soc
      2008;160:221-4.
88.   Hiller D, Chu QD, Meschonat C, Panu L, Burton G, Li B. Reduction in eIF4E level correlates
      with improved breast cancer outcome in patients treated with neoadjuvant chemotherapy. J
      Surg Research 2009;151:260.
89.   Flowers A, Chu QD, Panu L, Caldito G, Meschonat C, Li B. Eukaryotic initiation factor 4E
      (eIF4E) overexpression in triple-negative breast cancer and clinical outcome. J Surg Research
      2009;151:179.
90.   Pennington K, Jung J, Nedeljkovic-Kurepa A, Li BDL, Mathis JM, Chu QD. Testing an
      oncolytic adenovirus for cancer therapy using a novel ex vivo tissue slice model system. J Surg
      Research 2009;151:287.
91.   Chu QD, Smith M, Williams M, Panu L, Li B.D., Glass J. Race has no impact on breast cancer
      outcome: Results of 803 patients treated at a public hospital. AACR 2009
92.   Chu QD, Mizell J, Panu L, Johnson L, Ampil F, Turnage R, Li BDL. Elevated Level of
      CXCR4 in Primary Tumors of HER-2 Negative Breast Cancers Portends a Poor Disease-Free



                                                   24
      Survival: A Validation Study. Ann Surg Oncol 2009;16(S1):57.
93.   Smith M, Cole P, Chu Q, Li BD. SIRT 1 Expression and Colon Cancer. Ann Surg Oncol
      2009;16(S1):86.
94.   Smith M, Li BD, Sun G, Chu QD. CXCR4 expression is not associated with HER-2 status or
      mTOR expression levels. ASCO 2009
95.   Kleiner H, Krishnan P, Tubbs J, Smith M, Meschonat C, Shi R, Lowery-Nordberg M,
      Adegboyeaga P, Unger M, Cardelli J, Chu Q, Mathis J, Clifford J, DeBenedetti A, Li B.
      Tissue microarray analysis of eIF4E and its downstream effector proteins in human breast
      cancer. J Experimental & Clin Cancer Res 2009;28:54 doi: 10.1186/1756-9966-28-5.
96.   Flowers A, Chu QD, Panu L, Meschonat C, Caldito G, et al. Eukaryotic initiation factor 4E
      overexpression in triple-receptor breast cancer predicts a worse outcome. Surgery
      2009;146:220-6.
97.   Mizell J, Panu L, Johnson L, Ampil F, Turnage R, Li BDL, Chu QD. Overexpression of
      CXCR4 in Primary Tumor of Patients with HER-2 Negative Breast Cancer was Predictive of a
      Poor Disease-Free Survival: A Validation Study. Ann Surg Oncol 2009;16:2711-16.
98.   Chu QD, Smith M, Williams M, Panu L, et al. Race/ethnicity has no effect on outcome for
      breast cancer patients treated at an academic center with a public hospital. Cancer Epidemiol
      Biomarkers Prev 2009;18:2157-61.
99.   Chu QD, Panu L, Holm N, Li B, Johnson L, Zhang S. High chemokine receptor CXCR4 level
      in triple negative breast cancer specimens predicts poor clinical outcome. J Surg Res
      2010;159:689-95. DOI: 10.1016/j.jss.2008.09.020.
100   Hiller D, Chu Q, Meschonat C, Panu L, et al. Predictive value of eIF4E reduction after
      neoadjuvant therapy in breast cancer. J Surg Research 2009;156:265-9.
      DOI:10.1016/j.jss.2009.03.060.
101   Smith, M.H., De Benedetti, A., Sun, G., Meschonat, C., Burton, G.V., Caldito, G., Chu, Q.D.,
      Li, B.D.L. Concomitant eIF4E and TLK1B Overexpression in Doxorubicin-treated Breast
      Cancer. J Amer. Coll. Surgeons 209(3S): S119, 2009.
102   Chu QD, Pope M, Mathis JM, Sun G, Li B. A novel conditionally replicative adenovirus
      (Crad) increases infectivity efficiency and oncolytic activity in a human pancreatic
      adenocarcinoma cell line. 2009 Louisiana Gene Therapy Research Consortium Symposium,
      page 36, poster 26.
103   Chu QD, Glass J. Findings that hospital factors are surrogate for disparities are misleading.
      DOI: 10.1200/JCO.2009.26.1107. JCO 2010;28:e56.
104   Grand R, Sun G, Chung J, Meschonat C, Li BD, Chu QD. Hypoxia-Inducible Factor-1α (HIF-
      1α) Mediates Chemokine Receptor CXCR4 Expression under Hypoxic Condition in Human
      Pancreatic Cancer Line CFPAC-1. JSR 2010;158:194.
105   Henderson A, Burton G, Parker C, Ampil F, Li BD, Chu QD. Race/Ethnicity Has No Impact
      on Outcome for Patients with Triple-Receptor Negative Breast Cancer. JSR 2010;158:262.
106   Pennington K, Mathis M, Li BD, Chu QD. Testing a tropism-modified conditionally
      replicative adenovirus for breast cancer in a tissue slice model system. JSR 2010;158:398.
107   Hiller D, Meschonat C, Madumere P, Li B, Chu QD. Persistently Elevated Chemokine
      Receptor CXCR4 in Primary Tumors Following Neoadjuvant Chemotherapy is a Novel
      Predictive Molecular Marker for Patients with Locally Advanced Breast Cancer. JSR
      2010;158:190.
108   Parker C, Smith M, Henderson A, Li BD, Ampil F, Chu QD. Breast Conservation Therapy is a
      Viable Option for Patients with Triple-Receptor Negative Breast Cancer. JSR 2010;158:177.



                                                  25
109 Chu Q, Sun G, Li B, Mathis M. Oncolytic activity of a novel conditionally replicative
    adenovirus (CRAd) against PANC-1 pancreatic adenocarcinoma cells. HPB 2010;12:101.
110 Jafarimehr E, Dabbous H, Zibari G, Chu Q, LaRoux S, et al. Major pancreatic surgery, a safe
    procedure. HPB 2010;12:342.
111 D’Agostino H, Suzuki I, Zibari G, Shokouh-Amiri H, Crow K, Mogghadam S, Vea R, Chu Q,
    et al. Multidisciplinary management of acute pancreatitis complications: experience in 104
    patients. HPB 2010;12:423.
112 Pennington K, Chu QD, Curiel DT, Li BD, Mathis JM. The utility of a tissue slice model
    system to determine breast cancer infectivity by oncolytic adenoviruses. J Surg Research 2010;
    doi:10.1016/j.jss.2010.03.072.
113 Chu QD, Burton G, Glass J, Smith M, Li BD. Impact of Race and Ethnicity on Outcomes for
    Estrogen Receptor-Negative Breast Cancers: Experience of an Academic Center with a Charity
    Hospital. J Am Coll Surg 2010;210:585-94.
114 Parker C, Ampil F, Burton G, Li B, Chu QD. Is breast conservation therapy a viable option for
    patients with triple-receptor negative breast cancer? Surgery 2010;148:386-91.
115 Chu QD, Holm N, Madumere P, Johnson L, Abreo F, Li B. Chemokine receptor CXCR4
    overexpression predicts recurrence for hormone-receptor positive, node-negative breast cancer
    patients. Surgery 2011;149:193-9; doi:10.1016/j.surg.2010.05.016.
116 Li B, Sicard M, Ampil F, Abreo F, Lilien D, Chu QD, Burton G. Trimodal therapy for
    inflammatory breast cancer: a surgeon’s perspective. Oncology 2010;79:3-12.
117 Kim R, Li B, Chu QD. The role of chemokine receptor CXCR4 in the biologic behavior of
    human soft tissue sarcoma. Sarcoma 2010. doi:10.1155/2011/593708.
118 Chu QD, Nguyen T, McNamara L, Nguyen P, Li B.D, Barish R, Ho H. Is cost the reason for
    the lack of a sustaining “twinning” surgical program between the U.S. and a developing
    country? Experience with a university in Vietnam. J Surg Research 2011;165:173.
119 Hiller D, Meschonat C, Kim R, Li BD, Chu QD. Chemokine receptor CXCR4 level in primary
    tumors independently predicts outcome for patients with locally advanced breast cancer. J Surg
    Research 2011;165:179.
120 Pope M, Mathis J, Sun G, Kim R, Li BD, Chu QD. CXCR4 tumor specific promoter restricts
    oncolysis to pancreatic cancer cell lines that overexpress CXCR4. J Surg Research
    2011;165:304.
121 Pope M, Mathis J, Sun G, Kim R, Li BD, Chu QD. A novel modified oncolytic adenovirus
    Ad5/3-CXCR4 exhibits potent antitumor effect and limited host toxicity against xenograft
    human pancreatic cancers on SCID mice. J Surg Research 2011;165:305.
122 Kim RH, Chu QD, Zibari GB, Eggerstedt JM, Li BD. Prior presentation experience, not
    education on effective use of PowerPoint, predicts quality of resident research presentations. J
    Surg Research 2011;173.
123 Arnold A, Caldito G, Rinaudo C, Chu QD, Li BD, Eggerstedt J, Kim R. Impact of a program
    of early clinical exposure on medical students’ residency choices of primary care and surgical
    fields. J Surg Research 2011;165:173.
124 Hiller D, Li B, Chu QD. CXCR4 as a predictive marker for locally advanced breast cancer
    post-neoadjuvant therapy. J Surg Research 2011;166:14-8.
125 Davezac L, Sicard M, Chu QD, Kim RH, DeBenedetti A, Li B. High TLK1B Overexpression
    in breast cancer predicts doxorubicin resistance. Ann Surg Onc 2011;18:S53.
126 Parker C, Johnson L, Panu L, Li B, Chu QD. The chemokine receptor CXCR4 as a novel
    independent prognostic marker for node positive breast cancer patients. Ann Surg Onc



                                                  26
    2011;18:S65.
127 Ampil F, Li B, Burton G, Kim R, Chu QD, Baluna R. Is baseline bone imaging in high-risk
    breast cancer patients justified? Breast Journal.

     BOOK

     Chu Q, Ho H (Editors). Surgical Care at the District Hospital, the World Health Organization.
     Medical translation into Vietnamese 2010.

     SUBMITTED

1.  Parker C, Panu L, Li B, Johnson L, Chu QD. The chemokine receptor CXCR4 as a novel
    independent prognostic marker for node positive breast cancer patients (accepted to SSO)
2. Henderson A, Burton G, Glass J, Li B, Chu QD. Outcome for patients with triple-receptor
    negative breast cancer is not dependent on race/ethnicity.
3. Grand R, Chung J, Li B, Chu QD. Hypoxia-inducible factor-1α mediates chemokine receptor
    CXCR4 expression under hypoxia in human pancreatic cancer cell line CFPAC-1.
4. Chu QD, Zibari G, Ho H. Surgical Volunteerism in Vietnam: Our Role as Surgeons and
    Educators in Strengthening U.S.-Vietnam Relationship.
5. Hiller D, Meschonat C, Li B, Kim R, Chu QD. Chemokine Receptor CXCR4 Level in Primary
    Tumors Independently Predicts Outcome for Patients with Locally Advanced Breast Cancer
6. Chu QD, Pope M, Sun G, Curiel DT, Li B, Mathis JM.Virotherapy Using a Novel Chimeric
    Oncolytic Adenovirus Prolongs Survival in a Human Pancreatic Cancer Xenograft Model.
7. Chu QD, Ho H. Cost Analysis of Establishing a Relationship between a Surgical Program in
    the U.S. and one in Vietnam.
8. Kim R, Chu QD, Zibari G, Eggerstedt J, Li B. Prior presentation experience, not education on
    effective use of PowerPoint, predicts quality of resident research presentation.
9. Arnold A, Caldito G, Rinaudo C, Chu QD, Li BL, Eggerstedt J, Kim R. Impact of a program
    of early clinical exposure on medical students’ residency choices of primary care and surgical
    fields.
10. Chu QD, Jaganmohan S, Kelly B, Hobley J. Verrucous Carcinoma of the Esophagus: A rare
    variant of squamous cell carcinoma for which a preoperative diagnosis can be a difficult one to
    make.

     ACCEPTED FOR PRESENTATIONS:
1.    Parker C, Panu L, Li B, Johnson L, Chu QD. The chemokine receptor CXCR4 as a novel
      independent prognostic marker for node positive breast cancer patients (accepted to SSO)
2.

     CHAPTERS, EDITORIALS, AND OTHER NON-REFEREED
     PUBLICATIONS:

1.    Chu QD, Zibari G, Turnage R. Gastric Surgery. In Johnson LR (ed) Encyclopedia of


                                                   27
     Gastroenterology 2004; p. 152-6.
2.   Turnage R, Johnson LW, Chu QD. Gastric Outlet Obstruction. In Johnson LR (ed)
     Encyclopedia of Gastroenterology 2004; p. 138-140.
3.   Turnage R, Johnson LW, Chu QD. Marginal Ulcer. In Johnson LR (ed) Encyclopedia of
     Gastroenterology 2004; p. 624-6.
4.   Turnage R, Johnson LW, Chu QD. Volvulus. In Johnson LR (ed) Encyclopedia of
     Gastroenterology 2004; p. 627-30.
5.   Chu QD, McDonald JC, Li BDL. Adjuvant Therapy for Patients with Node-Positive Breast
     Cancer. In Cameron, Advances in Surgery 2006; 40:77-98.
6.   Chu QD, Holm N, Byrnes K, Li BDL. Translational Research in Breast Cancer. Surgical
     Oncology Clinics of North America 2008;17:421-38.
7.   Upton B, Chu Q, Li BD. Li-Fraumeni Syndrome: The genetics and treatment considerations
     for the Sarcoma and Associated Neoplasms. Surgical Oncology Clinics of North America
     2009;18:145-56.
8.   Chu QD. Hue Oncology Program Description. For Health Volunteers Overseas and ASCO
     November 2010.


     INVITED LECTURESHIPS AND PRESENTATIONS:

1.  "The Role of Adjuvant Therapy for Patients with Resected Stage II Colon Cancer ”
    Roswell Park Cancer Institute. Buffalo, NY. Sept., 2001.
2. “Adjuvant Therapy is Not Indicated for Patients with Resected Pancreatic Cancer"
    Roswell Park Cancer Institute. Buffalo, NY. Sept., 2002.
3. “Current Perspectives on Pancreatic Adenocarcinoma”
    LSUHSC Department of Surgery Grand Rounds, Shreveport, LA 2002.
4. “Management of Retroperitoneal Sarcoma”
    LSUHSC Department of Surgery Grand Rounds, Shreveport, LA 2003.
5. “Current Perspectives on Gastric Adenocarcinoma”
    LSUHSC Department of Surgery Grand Rounds, Shreveport, LA, 2004.
6. “Controversies in the Surgical Approach to Colorectal Cancer: Routine Open Colectomy –vs-
    Laparoscopic Colectomy for Colorectal Carcinoma”
    6th Annual Red River Gastrointestinal Conference, Shreveport, LA 2004
7. “Cap-Dependent Translation Control”
    LSUHSC Dept. of Surgery Grand Rounds, Shreveport, LA, 2004.
8. “Current Surgical Management of Primary and Metastatic Gastrointestinal Carcinoid Tumors”
    2nd Annual Phoenix Multidisciplinary Cancer Symposium, Phoenix, Arizona, October 8th 2005
9. “Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemo-Perfusion (IPHC) for the
    Treatment of Peritoneal Carcinomatosis” Feist-Weiller Cancer Center, Shreveport, LA
    November 21, 2005
10. “Current Perspectives on the Management of Esophageal Cancer”
    LSUHSC Department of Otolaryngology Grand Rounds, Shreveport, LA 2006
11. “Recurrence in Node-Positive Breast Cancer”
    LSUHSC Department of Otolaryngology Grand Rounds, Shreveport, LA April 11, 2006
12. “Management of Recurrent and Locally Advanced Colorectal Cancer”


                                               28
      Louisiana Cancer Control Partnership Annual Conference, Baton Rouge, LA 2006
13.   “Management of Recurrent and Locally Advanced Breast Cancer”
      Louisiana Cancer Control Partnership Annual Conference, Baton Rouge, LA 2006
14.   Moderator for Liver and Biliary Symposia. International College of Surgeons, North American
      Federation. Reno Nevada, 2008
15.   Discussant for Genetic Determinants of Disease and Outcomes of the 94th Annual Clinical
      Congress of the American College of Surgeons, San Francisco, CA Oct 12-16, 2008.
16.   Role of Chemokine Receptor CXCR4 in Breast Cancer. 2009 SWOG Spring meeting, April 30
      –May 4, 2009.
17.   Moderator for 16th Annual Feist Weiller Cancer Symposium on Hepatocellular Carcinoma.
      Shreveport, LA July 17, 2009.
18.   Moderator for 1st Annual Hepato-pancreato-biliary Symposium. Shreveport, LA November
      20, 2009.
19.   “The Role of a Surgical Oncologist in the Community”. Barksdale Airforce Base, Barksdale,
      LA., February 25, 2010.
20.   Moderator for 17th Annual Feist Weiller Cancer Symposium on Esophageal Carcinoma.
      Shreveport, LA July 23, 2010.
21.   Leo W. Jenkins Cancer Center as a Nationally Recognized Center of Excellence. East Carolina
      University. July 19, 2010.
22.   American College of Surgeons 2011 Annual Meeting. Moderator for the 97th Annual Clinical
      Congress, “Volunteering: Making Service Happen”. San Francisco, CA , October 23-27, 2011.
23.   Vietnam Education Foundation 2011 Annual Meeting. Invited Speaker “Capacity Building.
      What Can One Achieve in One Year”. University of Arkansas, AR, January 2-5, 2010.
24.   Vietnam Education Foundation 2011 Annual Meeting. Invited Discussant “Building
      Leadership Skills”. University of Arkansas, AR, January 2-5, 2010.
25.   Vietnam Education Foundation 2011 Annual Meeting. Invited Discussant “Networking for
      Success”. University of Arkansas, AR, January 2-5, 2010.
26.   Moderator for Louisiana Chapter of the American College of Surgeons Annual Meeting
      January 21-23 Annual Meeting, Shreveport, Louisiana.
27.   Moderator for 97th Annual Clinical Congress of American College of Surgeons, “Volunteering:
      Making Service Happen”. San Francisco, CA , October 23-27, 2011



      PRESENTATIONS AT PROFESSIONAL MEETINGS:
        1993

1.      Thrombotic Thrombocytopenic Purpura (TTP) and HIV Infection.
        American College of Physicians-Rhode Island Scientific Meeting, Providence, RI
2.      Metastatic Dermatofibrosarcoma Protuberans with Fibrosarcomatous Areas:
        New England Hand Society, Boston, MA
3.      Giant Condyloma Acuminatum (Buschke-Loewenstein Tumor) of the Anorectal and
        Perianal Region: Analysis of 42 Cases
        New England Cancer Society, Boston, MA




                                                 29
      1994

4.    The Role of Hepatic Re-Resection for Metastatic Colorectal Cancer
      New England Cancer Society, Boston, MA

      1995

5.    Metastatic Squamous Cell Carcinoma (SCC) to the Neck from Unknown Primary.
      American Radium Society
6.    Biphasic Effect of Cisplatin and Taxol on B16F10 Melanoma Cells.
      American Association for Cancer Research
7.    Patient Selection for Hepatic Resection of Colorectal Metastases.
      New England Surgical Society, Montreal, Canada
8.    Repeat Hepatic Resection for Recurrent Colorectal Cancer
      Society of Surgical Oncology
9.    Purification of a Novel Human Antitumor Factor: Normal Human Globulin (NHG) from
      Normal Human Serum.
      J. Murray Beardsley Surgeon-in-Chief Pro Tempore, Providence, RI

      1996

10.   Age, Mechanism of Injury, and Injury Severity Score as Predictors of Financial Outcome in
      Regional Pediatric Trauma Care: A New Outcome-Based Injury Prevention Strategy.
      American College of Surgeons, San Francisco, CA

      1997

11.   Cost Analysis of Pediatric Trauma Care by Cost Centers and Mechanisms of Injury as a
      Basis for Injury Prevention and Clinical Guidelines.
      Western Trauma Association, Snowbird, Utah
12.   The Economic Burden of Preventable Pediatric Traumas to An Urban Level I Trauma
      Center.
      Massachusetts American College of Surgeons Committee on Trauma, Boston, MA

      1998

13.   Delayed Hemothorax Following Blunt Thoracic Trauma. An Uncommon Entity with
      Significant Morbidity
      Eastern Association for the Surgey of Trauma


      1999

14.   The Management of Breast Cancer.
      General Surgery at the Millenium: Nursing Education Symposium, Boston, MA



                                                30
      2000

15.   The Management of Thyroid Cancer.
      Nursing Education Symposium III. Surgery for a Multidisciplinary Age, Boston, MA

      2001

16.   Abdominoperineal Resection as an Option for Patients with Stage IV Adenocarcinoma of the
      Rectum.
      2nd Cancer Symposium of World Federation of Surgical Oncology Societies, Naples, Italy
17.   Squamous Cell Carcinoma of the Lip: Nodal Stage Remains the Most Accurate Predictor of
      Outcome for Stage III/IV Disease.
      American Head and Neck Society, Palm Desert, CA

      2002

18.   Predictive Factors Associated with Long Term Survival in Patients with Neuroendocrine
      Tumor of the Pancreas.
      Society of Surgical Oncology, Denver, CO
19.   Phase II Trial of Infusional 5-Fluorouracil, Mitomycin C, and External Beam Radiation
      Followed by Pancreatectomy for Patients with Locally Advanced Adenocarcinoma of the
      Pancreas. A Long-Term Follow-up.
      American Society of Clinical Oncology,
20.   Neuroendocrine Tumors of the Pancreas. The Roswell Park Experience.
      Society of Black Academic Surgeons, Atlanta, GA
21.   Parathyroid Carcinoma: A 30 year Review of the Western New York Experience.
      American Academy of Otolaryngology Head & Neck Surgery, San Diego, CA
22.   HsMCM2/BM28: A Potentially Better Proliferation Marker than Ki-67 for Squamous Cell
      Carcinoma of the Head and Neck.
      American Society of Clinical Oncology,
23.   Immunohistochemical Evaluation of Urinary Plasminogen Activator (uPA), its Receptor
      (uPAR), matrixmetalloproteinases-9 (MMP-9) and von Willebrand Factor (vWF) in
      Pancreatic Cancer.
      American Association for Cancer Research, San Francisco, CA
24.   Neoadjuvant Chemoradiation Followed by Surgery for Locally Advanced Adenocarcinoma
      of the Pancreas: The Roswell Park Experience.
      Society of Black Academic Surgeons, Atlanta, GA
25.   Urinary Plasminogen Activator (uPA) is Expressed in Papillary Thyroid Carcinoma but Not
      in Benign Thyroid Tumor.
      American Head and Neck Society, Boca Raton, FL

      2003

26.   High eIF4E Predicts Recurrence in Node-Negative Breast Cancer Patients.
      American Society for Clinical Oncology, Chicago, IL



                                               31
27.   High eIF4E Predicts Cancer Recurrence in Node-positive Breast Carcinoma.
      American Association for Cancer Research, Washington D.C.
28.   Referral to American Cancer Society May Not Improve the Quality of Life for Patients with
      Breast Cancers.
      Lynn Sage Cancer Symposium, Chicago, IL
29.   Neoadjuvant Chemotherapy Attenuates the Overexpression of eIF4E in Patients with Breast
      Carcinomas.
      Frontiers in Cancer Prevention Research, AACR, Phoenix, AZ
30.   Radical Resection is Indicated For All T2 and T3 Gallbladder Cancers and Results in the
      Same Survival as Primarily Resected Gallbladder Cancers.
      Society of Surgical Oncology, New York City, NY

      2004

31.   Impact of eIF4E Overexpression On Survival In Advanced Breast Cancer.
      Joint Annual Meeting of the LA-Chapter, American College of Surgeons & Surgical
      Association of Louisiana, New Orleans, LA
32.   Eukaryotic Initiation Factor 4E (eIF4E) is Overexpressed in Patients with Soft Tissue
      Neoplasms.
      American Association for Cancer Research, Orlando, FL
33.   Overexpression of eIF4E is Attentuated Following Neoadjuvant Chemotherapy for Patients
      with Breast Carcinomas.
      Barlow Symposium, Shreveport, LA
34.   eIF4E Overexpression Portend a Poorer Survival for Patients with Advanced Breast Cancer.
      Barlow Symposium, Shreveport, LA
35.   The Risk for malignancy in PET-Positive Thyroid Incidentalomas.
      American Society of Clinical Oncology, New Orleans, LA
36.   A Translational Restricted HSV-TK/GCV Gene Increases Disease-free and Overall Survival
      in a Minimal Residual Disease Rat Breast Cancer Model.
      Association for Academic Surgery, Houston, TX
37.   FDG-PET Imaging of Suspicious Breast Lesions Developing After Breast Conservation
      Therapy for Breast Cancer.
      American Society of Clinical Oncology, New Orleans, LA
38.   Therapeutic Efficacy of Translational Restricted Modified HSK-TK/GCV Gene Therapy
      Following Tumor Cytoreduction in a Syngeneic Rat Model for Breast Cancer.
      Barlow Symposium, Shreveport, LA
39.   Breast Conservation Therapy Can Be An Acceptable Alternative For Breast Cancer Patients
      With Collagen Vascular Disease.
      Society of Surgical Oncology, NYC, NY
40.   Positron Emission Tomography is a Useful Modality for the Detection of Metastasis in
      Symptomatic Patients with Stage II and III Breast Cancer.
      American Society of Clinical Oncology, New Orleans, LA
41.   Impact Of eIF4E Overexpression On Survival In Advanced Breast Cancer. Society of
      Surgical Oncology, NYC, NY
42.   Thoracic Metastases from Breast Cancer: A 23-year Review of Patients. European
      Respiratory Society Glasgow 2004 Congress, Glasgow, Ireland



                                               32
      2005

43.   Impact of Neoadjuvant Therapy on Stage III Breast Cancer Outcome. Southeastern Surgical
      Association 2005
44.   Using an Ad-HSV-UTK Gene Construct to Exploit eIF4E Overexpression in Tumor Cells to
      Improve Outcome. Society of University Surgeons 2005, Nashville, TN
45.   Eukaryotic Initiation Factor 4E (eIF4E) Expression in Malignant Versus Inflammatory
      Colon Tissue. Society of Surgical Oncology 2005, Atlanta, GA
46.   Initiation Factor 4E (eIF4E) and Cancer Recurrence in Node-Positive Breast Carcinoma.
      American Surgical Association 2005; Palm Beach, FL
47.   Effect of neoadjuvant chemotherapy on eIF4E expression in breast carcinoma. Society of
      Surgical Oncology 2005, Atlanta, GA
48.   PET Scan and Stage II and III Breast Cancer.
      Joint Meeting of the LA-Chapter, Amer Coll of Surgeons/Surg Assoc LA, New Orleans, LA
49.   Role of Neoadjuvant Chemotherapy in Patients With Advanced Breast Cancer.
      Joint Meeting of the LA-Chapter, Amer Coll of Surgeons/Surg Assoc LA, New Orleans, LA
50.   Risk of Malignancy in PET Scan Detected Thyroid Incidentaloma
      Joint Meeting of the LA-Chapter, Amer Coll of Surgeons/Surg Assoc LA, New Orleans, LA
51.   Eukaryotic Initiation Factor 4E (eIF4E) Targeted Gene Therapy Increases Disease-Free and
      Overall Survival in a Minimal Residual Disease Rat Breast Cancer Model.
      Joint Meeting of the LA-Chapter, Amer Coll of Surgeons/Surg Assoc LA, New Orleans, LA
52.   Neoadjuvant Chemotherapy In Stage III Breast Cancer.
      Southeastern Surgical Congress, New Orleans, LA
53.   eIF4E Overexpression, Angiogenesis, and Breast Cancer Outcome
      Annual Meeting of the Southern Surgical Association, Hot Spring, VA

      2006
48.   Apoptosis in a Malignant Cell Line Induced by a Novel Suicide Gene Therapy Exploiting
      Elevated Levels of Eukaryotic Initiation Factor 4E. Academic Surgical Congress 2006, San
      Diego, CA
      Correlation of TLK1B in Elevation and Recurrence in Doxorubicin-treated Breast Cancer
      Patients with High eIF4E overexpression. Southern Surgical Association 2006, West Palm
      Beach, FL
49.   Upregulation of TLK1B by eIF4E overexpression predicts cancer recurrence in irradiated
      breast cancer patients. Academic Surgical Congress 2006, San Diego, CA
50.   Cost Analysis of Breast Conservation Therapy versus Simple Mastectomy with or without
      Reconstruction for Patients with Ductal Carcinoma In-Situ (DCIS). Society of Surgical
      Oncology 2006, San Diego, CA
54.   eIF4E overexpression and Clinical Outcome in Node-negative Breast Cancer Patients – An
      Interim Analysis
      Joint Meeting of the LA-Chapter, Amer Coll of Surgeons/Surg Assoc LA, New Orleans, LA




                                               33
55.   The Overexpression of eIF4E in Malignant Versus Inflammatory Colon Tissue.
      Joint Meeting of the LA-Chapter, Amer Coll of Surgeons/Surg Assoc LA, New Orleans, LA

      2007

56.   High chemokine receptor CXCR4 in cancer specimens predicts recurrence in HER-2
      negative breast cancer. Second Annual Academic Surgical Congress February 2007, AAS,
      Phoenix, AZ
57.   A novel suicide gene therapy targeting the overexpression of eukaryotic initiation factor 4E
      improves survival in a rat model of peritoneal carcinomatosis. Second Annual Academic
      Surgical Congress February 2007, SUS, Phoenix, AZ
58.   Risk for residual cancer after a margin-positive biopsy. 60th Annual Cancer Symposium.
      Society of Surgical Oncology 2007, Washington, DC.
59.   Multi-dosing of a novel suicide gene therapy targeting the overexpression of eukaryotic
      initiation factor 4E improves outcome in a rat model of peritoneal carcinomatosis. 2nd
      International Symposium on Regional Cancer Therapies 2007, San Juan, Puerto Rico
61.   A novel conditionally replicative adenovirus gene therapy targeting overexpression of
      chemokine receptor CXCR4 in a pancreatic cancer cell line. 7th American Hepato-
      Pancreato-Biliary Congress 2007, Las Vegas, Nevada
62.   A novel suicide gene therapy regimen targeting the overexpression of eukaryotic initiation
      factor 4E in a pancreatic cancer cell line. 7th American Hepato-Pancreato-Biliary Congress
      2007, Las Vegas, Nevada.
63.   Long bone metastases in breast cancer: Experience of 47 patients. 4th Congress
      of the World Society for Breast Health, Tianjin, China, October 21, 2007

      2008

64.   Chemokine Receptor CXCR4 overexpression predicts recurrence for hormone-receptor
      positive, node-negative breast cancer patients. 3rd Annual Academic Surgical Congress
      2008, Huntington Beach, CA
65.   Translation initiation factor eIF4E targeted suicide gene therapy following cytoreductive
      surgery improves disease-free survival in a mouse soft tissue metastasis model for head and
      neck squamous cell carcinoma. 3rd Annual Academic Surgical Congress 2008, Huntington
      Beach, CA.
66.   Hypoxia induces CXCR4 overexpression in pancreatic cancer cells. AACR 2008, San
      Diego, CA.
67.   Cancerization of the lobules with pre-invasive or early invasive carcinoma of the breast:
      Management and outcome study. World Cancer Congress UICC 2008, Geneva, Switzerland.
68    Overexpression of chemokine receptor CXCR4 in cancer specimens predicts outcome in
      patients with triple-negative breast cancer. Annual meeting of the American Society of
      Clinical Oncology 2008, Chicago, IL.

      2009




                                                 34
69    Eukaryotic initiation factor 4E (eIF4E) overexpression in triple-negative breast cancer and
      clinical outcome. 4th Annual Academic Surgical Congress, Fort Myers, FL February 3-6,
      2009
70.   Reduction in eIF4E level correlates with improved breast cancer outcome in patients treated
      with neoadjuvant chemotherapy. 4th Annual Academic Surgical Congress, Fort Myers, FL
      February 3-6, 2009
71.   Testing an oncolytic adenovirus for cancer therapy using a novel ex vivo tissue slice model
      system. 4th Annual Academic Surgical Congress, Fort Myers, FL February 3-6, 2009
72.   Race has no impact on breast cancer outcome: Results of 803 patients treated at a public
      hospital. Second AACR Conference on the Science of Cancer Health Disparities in
      Racial/Ethnic Minorities and the Medically Underserved, Carefree, AZ February 3-6, 2009
73.   Elevated Level of CXCR4 in Primary Tumors of HER-2 Negative Breast Cancers Portends a
      Poor Disease-Free Survival: A Validation Study. 62nd Annual Cancer Symposium of the
      Society of Surgical Oncology, March 5-8, 2009, Phoenix, AZ.
74.   SIRT 1 and eIF4E in Colon Cancer Outcome. 62nd Annual Cancer Symposium of the Society
      of Surgical Oncology, March 5-8, 2009, Phoenix, AZ.
75.   CXCR4 Chemokine Receptors and its Prognostic Significance in Breast Carcinoma. 2009
      SWOG Spring Meeting, April 30-May 4, 2009, Chicago, IL.
76.   Fundamentals of Clinical Surgery. Vietnam Education Foundation 2009 Meeting, June 22,
      2009, Washington D.C.
77.   SIRT 1 and eIF4E in Colorectal Cancer Outcome. The American Society of Colon and
      Rectal Surgeons Annual Scientific Meeting, Hollywood, FL May 2-6, 2009.
78.   Concomitant eIF4E and TLK1B overexpression in doxorubicin-treated breast cancer.
      Surgical Forum, October 12, 2009, Chicago, IL.
79.   A novel conditionally replicative adenovirus (Crad) increases infectivity efficiency and
      oncolytic activity in a human pancreatic adenocarcinoma cell line. 2009 Louisiana Gene
      Therapy Research Consortium Symposium October 14, 2009, New Orleans, LA.
80.   Impact of Race/Ethnicity on Outcome for ER-Negative Breast Cancers: Experience of an
      Academic Center with a Charity Hospital. Southern Surgical Association, 121st Annual
      Meeting, Hot Springs, VA, December 6-9, 2009.
81.   The Value of a Surgical Morbidity and Mortality Conference. Thai-Binh Medical
      University, Vietnam, December 15, 2009.


      2010

82.   Hypoxia-Inducible Factor-1α (HIF-1α) Mediates Chemokine Receptor CXCR4 Expression
      under Hypoxic Condition in Human Pancreatic Cancer Line CFPAC-1. 5th Annual
      Academic Surgical Congress 2010, San Antonio, TX, February 3-5, 2010.
83.   Race/Ethnicity Has No Impact on Outcome for Patients with Triple-Receptor Negative
      Breast Cancer. 5th Annual Academic Surgical Congress 2010, San Antonio, TX, February 3-
      5, 2010.
84.   Testing a tropism-modified conditionally replicative adenovirus for breast cancer in a tissue
      slice model system. 5th Annual Academic Surgical Congress 2010, San Antonio, TX,
      February 3-5, 2010.




                                                 35
85.    Persistently Elevated Chemokine Receptor CXCR4 in Primary Tumors Following
       Neoadjuvant Chemotherapy is a Novel Predictive Molecular Marker for Patients with
       Locally Advanced Breast Cancer. 5th Annual Academic Surgical Congress 2010, San
       Antonio, TX, February 3-5, 2010.
86.    Breast Conservation Therapy is a Viable Option for Patients with Triple-Receptor Negative
       Breast Cancer. 5th Annual Academic Surgical Congress 2010, San Antonio, TX, February 3-
       5, 2010.
87.    Fundamentals of Clinical Surgery. 7th Annual Meeting of Vietnam Education Foundation
       (VEF). January 2-4, 2010, Troy, New York.
88.    Disparities in Breast Cancer: LSUHSC-S/FWCC Experience. John C. McDonald Surgical
       Society 2010 Annual Alumni Meeting: March 20, 2010, Eldorado Resort & Casino,
       Shreveport, LA.
89.    Oncolytic activity of a novel conditionally replicative adenovirus (CRAD) against PANC-1
       pancreatic adenocarcinoma cells. 9th World Congress of the International Hepato-Pancreato-
       Biliary Association. April 18-22, 2010, Buenos Aires, Argentina.
90.    Multidisciplinary management of acute pancreatitis complications: experience in 104
       patients. 9th World Congress of the International Hepato-Pancreato-Biliary Association.
       April 18-22, 2010, Buenos Aires, Argentina.
91.    Major pancreatic surgery, a safe procedure. 9th World Congress of the International Hepato-
       Pancreato-Biliary Association. April 18-22, 2010, Buenos Aires, Argentina.
92.    Updates on Developing Oncology Program at Hue University Hospital, Vietnam.
       International Cancer Corps Working Group. 2010 ASCO Annual Meeting. June 3-8, 2010,
       Chicago, IL.
93.    ASCO Membership Recruitment and Retention. ASCO Leadership Development Program
       Presentation. 2010 ASCO Annual Meeting. June 3-8, 2010, Chicago, I.L.
94.    What Does a Surgical Oncologist Do? Thai-Binh Medical University, Thai-Binh, Vietnam.
       June 28, 2010.
95.    Multidisciplinary Approach to Breast Cancer Care. Vietnam Education Foundation. June
       28, 2010.
96.    Barrett’s Esophagitis and its Progression to Cancer. 17th Annual Carroll W. Feist Scientific
       Symposium on Esophageal Carcinoma. July 23, 2010. LSU-Health Sciences Center-
       Shreveport, Shreveport, LA.
97.    Management of Operable Breast Cancer. First Annual International Vietnam-American
       Surgical Symposium. October 3, 2010. Hanoi, Vietnam.
98.    Current Perspectives on the Surgical Management of Breast Cancer. 2nd Annual University
       of Kansas Cancer Symposium. October 16, 2010. Kansas City, Kansas.
99.    The Surgical Management of Early Breast Cancer. Hue University College of Medicine and
       Pharmacy. September 28, 2010. Hue, Vietnam.


       2011

100.   Sustained Chemokine Receptor CXCR4 in Primary Tumors Following Neoadjuvant
       Chemotherapy is a Novel Predictive Molecular Marker for Patients with Locally Advanced
       Breast Cancer. Louisiana Chapter of the American College of Surgeons Annual Meeting
       January 21-23 Annual Meeting, Shreveport, Louisiana.



                                                 36
101.    Independent Prognostic Marker for Node Positive Breast Cancer Patients: Chemokine
        Receptor CXCR4. Louisiana Chapter of the American College of Surgeons Annual Meeting
        January 21-23 Annual Meeting, Shreveport, Louisiana.
102.    Is Breast Conservation Therapy a Viable Option for Patients with Triple-Receptor Negative
        Breast Cancer? Louisiana Chapter of the American College of Surgeons Annual Meeting
        January 21-23 Annual Meeting, Shreveport, Louisiana.
103.    Race/Ethnicity has no impact on outcome for patients with triple-receptor negative breast
        cancer. Louisiana Chapter of the American College of Surgeons Annual Meeting January
        21-23 Annual Meeting, Shreveport, Louisiana.
104.    Does early clinical exposure impact medical students’ choices of primary care and surgical
        residencies? Louisiana Chapter of the American College of Surgeons Annual Meeting
        January 21-23 Annual Meeting, Shreveport, Louisiana.
105.    Quality of resident research presentations: Impact of PowerPoint training versus prior oral
        presentation experience. Louisiana Chapter of the American College of Surgeons Annual
        Meeting January 21-23 Annual Meeting, Shreveport, Louisiana.
106.    Impact of a program of early clinical exposure on medical students’ residency choices of
        primary care and surgical fields. 6th Annual Academic Surgical Congress, February 1-3,
        2011, Huntington Beach, California.
107.    Prior presentation experience, not education on effective use of PowerPoint, predicts quality
        of resident research presentations. 6th Annual Academic Surgical Congress, February 1-3,
        2011, Huntington Beach, California.
108.    Is cost the reason for the lack of a sustaining “twinning” surgical program between the U.S.
        and a developing country? Experience with a university in Vietnam. 6th Annual Academic
        Surgical Congress, February 1-3, 2011, Huntington Beach, California.
109.    Chemokine receptor CXCR4 level in primary tumors independently predicts outcome for
        patients with locally advanced breast cancer. 6th Annual Academic Surgical Congress,
        February 1-3, 2011, Huntington Beach, California.
110.    CXCR4 tumor specific promoter restricts oncolysis to pancreatic cancer cell lines that
        overexpress CXCR4. 6th Annual Academic Surgical Congress, February 1-3, 2011,
        Huntington Beach, California.
111.    A novel modified oncolytic adenovirus Ad5/3-CXCR4 exhibits potent antitumor effect and
        limited host toxicity against xenograft human pancreatic cancers on SCID mice. 6th Annual
        Academic Surgical Congress, February 1-3, 2011, Huntington Beach, California.


   MEDIA PRESENTATIONS:

   1. “Colorectal Cancer: Screening, Treatment and Advances” KDAQ (National Public Radio
       Affiliate), Shreveport, LA, February, 2006.
   2.    Current Perspectives on Management of Colorectal Cancer. Louisiana Comprehensive
         Cancer Control Program. October 19, 2007.
   3. Race/ethnicity has no effect on outcome for breast cancer patients treated at an academic
   center with a public hospital. Lead article in LSU System Media Sweep 2009 and selected by
   The BreastCancer.Net News.
   4. Race Does Not Affect Breast Cancer Outcome, Says “Pivotal” Study.
   http://www.medscape.com/viewarticle/709542_print 2009 Medscape Medical News.


                                                   37
5. Study indicates race may not be independent predictor of overall breast cancer survival.
ASCO Cancer in the News, September 28, 2009. DailyCancerNews@asco.custombriefings.com.
6. Establishing a Breast Cancer Patient Navigator Program: The first of its kind at LSUHSC-
Shreveport, November 2, 2009.
7.     The Role of a Breast Cancer Patient Navigator. Community Renewal International.
Shreveport, Louisiana, November 13, 2009.
8. Equal treatment, equal outcomes in aggressive breast cancer: $10 million “down the drain?”
http://www.medscape.com/viewarticle/722544_print 2010 Medscape Medical News.
9.     Surgeon   grows    into   a     leader   in   Louisiana,    ASCO,      and    Beyond.
http://www.medscape.com/viewarticle/727838. 2010 Medscape Medical News.



MAJOR AREAS OF RESEARCH INTEREST

       (1) Role of CXCR4 chemokine receptor as a potential prognostic factor in HER-2
           negative breast cancers
       (2) Utilizing novel suicide gene therapy based on overexpression of eIF4E and CXCR4
           for the treatment of breast and pancreatic cancer
       (3) Utilizing novel oncolytic adenoviruses based on the overexpression of eIF4E and
           CXCR4 for the treatment of breast and pancreatic cancer
       (4) Development of a rat colorectal carcinomatosis model and utilizing cytoreductive
           surgery, intraperitoneal hyperthermic chemotherapy, and gene therapy to improve
           outcome
       (5) Cancer Disparities
       (6) Medical/Surgical Missions in Developing Countries




                                             38

								
To top